James F. Young, a Director of Novavax Inc, plans to sell 10,000 shares of common stock on December 24, 2024. The aggregate market value of the shares to be sold is $84,800, with an approximate price of $8.48 per share.The shares to be sold were acquired through stock plan activities over the past three years. Young received 4,600 shares on June 10, 2023, 1,400 shares on June 17, 2022, and 4,000 shares on June 25, 2021, all from the issuer. The transaction is yet to be completed.No securities have been sold by Young in the past three months prior to this announcement. The notice for this planned sale was filed on December 24, 2024, coinciding with the proposed sale date.

James F. Young, a Director of Novavax Inc, plans to sell 10,000 shares of common stock on December 24, 2024. The aggregate market value of the shares to be sold is $84,800, with an approximate price of $8.48 per share.The shares to be sold were acquired through stock plan activities over the past three years. Young received 4,600 shares on June 10, 2023, 1,400 shares on June 17, 2022, and 4,000 shares on June 25, 2021, all from the issuer. The transaction is yet to be completed.No securities have been sold by Young in the past three months prior to this announcement. The notice for this planned sale was filed on December 24, 2024, coinciding with the proposed sale date.